Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CPA1 | P15085 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | ACP3 | P15309 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL28046654 | 0.98 | GSR (0.53) | GSRNPC1ADAM17TRPA1ALDH1A1 | |
| SCHEMBL11043092 | 0.89 | GSR (0.46) | GSRTRPA1ALDH1A1LMNACYP2D6 | |
| SCHEMBL11130514 | 0.84 | GSR (0.47) | GSRNPC1ADAM17TRPA1ALDH1A1 | |
| SCHEMBL4851936 | 0.81 | ALDH1A1 (0.47) | GSRALDH1A1LMNAACP3MAPT | |
| SCHEMBL6258107 | 0.80 | ALDH1A1 (0.53) | NPC1ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL5164396 | 0.80 | ACHE (0.42) | GSRALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL2555564 | 0.80 | GABBR2 (0.47) | GSRCPA1CYP2D6SRCMAPT | |
| SCHEMBL2461330 | 0.80 | IGF1R (0.37) | GSRALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL2461283 | 0.80 | IGF1R (0.37) | GSRALDH1A1LMNAKDM4EMAPT | |
| SCHEMBL162874 | 0.79 | TAAR1 (0.48) | GSRNPC1ADAM17ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025007135-A9 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-03-27 | — | — | WO | claimed |
| WO-2025007135-A2 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-01-02 | — | — | WO | claimed |
| CN-105111086-A | 1-phenyl-2-nitroethanol and preparation method of derivatives thereof | UNIV NANJING INF SCI & TECH | 2015-12-02 | — | — | CN | claimed |
| US-20100148632-A1 | USE OF A PLASTICIZER IN AN ELECTROACTIVE POLYMER COMPOSITION | NEDERLANDSE ORGANISATIE VOOR TOEGEPASTNATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2010-06-17 | — | — | US | claimed |
| EP-2052019-A1 | USE OF A PLASTICIZER IN AN ELECTROACTIVE POLYMER COMPOSITION | Nederlandse Centrale Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek TNO (NL) | 2009-04-29 | — | — | EP | claimed |
| WO-2008010713-A1 | USE OF A PLASTICIZER IN AN ELECTROACTIVE POLYMER COMPOSITION | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2008-01-24 | — | — | WO | claimed |
| EP-1881024-A1 | Use of a plasticizer in an electroactive polymer composition | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO (NL) | 2008-01-23 | — | — | EP | claimed |
| EP-3808786-B1 | DEGRADABLE MICROSPHERE AND USE THEREOF | UNIV TSINGHUA (CN) | 2025-09-10 | — | — | EP | disclosed |
| US-12325767-B2 | Degradable microsphere and use thereof | TSINGHUA UNIVERSITY (CN) | 2025-06-10 | — | — | US | disclosed |
| CN-120054619-A | Catalyst for preparing chiral beta-amino alcohol and method for preparing chiral beta-amino alcohol using the same | 北京旭阳科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| WO-2025007135-A9 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-03-27 | — | — | WO | disclosed |
| WO-2025007135-A2 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-01-02 | — | — | WO | disclosed |
| CN-112106158-B | Electrolytic capacitor | 松下知识产权经营株式会社 | 2022-08-12 | — | — | CN | disclosed |
| WO-1995031469-A1 | PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-11-23 | — | — | WO | disclosed |
| EP-0389521-A4 | 2',5'-PHOSPHOROTHIOATE OLIGOADENYLATES AND ANTIVIRAL USES THEREOF | — | 1992-02-05 | — | — | EP | disclosed |
| EP-0389521-A1 | 2',5'-PHOSPHOROTHIOATE OLIGOADENYLATES AND ANTIVIRAL USES THEREOF | Temple University of the Commonwealth System of Higher Education (US) | 1990-10-03 | — | — | EP | disclosed |
| WO-1989003683-A1 | 2',5'-PHOSPHOROTHIOATE OLIGOADENYLATES AND ANTIVIRAL USES THEREOF | TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HI (US) | 1989-05-05 | — | — | WO | disclosed |
| US-4581178-A | USING TRANSITION METAL COMPLEXES CONTAINING PHOSPHINE OR ARSINE LI | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-08 | — | — | US | disclosed |
| US-4374061-A | ACTIVATION, AMINATION, AND DIAZOTIZATION OF A POLYSACCHARIDE FOLLOWED BY REACTION WITH A GLOBULIN; CHROMATOGRAPHY; SEPARATION OF GLYCOPROTEINS | CENTER FOR BLOOD RESEARCH, INC. (US) | 1983-02-15 | — | — | US | disclosed |
| US-4299992-A | Process for the selective hydroxymethylation of nitrotoluenes | REANAL FINOMVEGYSZERGYAR (HU) | 1981-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12325767-B2 | Degradable microsphere and use thereof | STUB1, PSMD14, ACP1 | GSR 3812/4885NPC1 4754/4885ADAM17 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.